[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  Embassy of Switzerland in Australia [@SwissEmbassyAUS](/creator/twitter/SwissEmbassyAUS) on x 1296 followers Created: 2025-07-23 09:01:09 UTC Novartis has received approval for its anti-malaria drug Coartem Baby. It is the first treatment specifically designed for babies, the primary victims of the disease. Until now, they were treated with tablets for older children, adjusted for weight. ℹ️:  XX engagements  **Related Topics** [babies](/topic/babies) [australia](/topic/australia) [switzerland](/topic/switzerland) [novartis](/topic/novartis) [$novnsw](/topic/$novnsw) [stocks healthcare](/topic/stocks-healthcare) [Post Link](https://x.com/SwissEmbassyAUS/status/1947945065654952195)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Embassy of Switzerland in Australia @SwissEmbassyAUS on x 1296 followers
Created: 2025-07-23 09:01:09 UTC
Novartis has received approval for its anti-malaria drug Coartem Baby. It is the first treatment specifically designed for babies, the primary victims of the disease. Until now, they were treated with tablets for older children, adjusted for weight. ℹ️:
XX engagements
Related Topics babies australia switzerland novartis $novnsw stocks healthcare
/post/tweet::1947945065654952195